Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100PKQH
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-04-01 → 2021-09-30StandaloneNet sales
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income¥226m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥223m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥221m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥145m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.8bnat 2022-09-30StandaloneAssets
Total assets¥2.5bnat 2022-03-31StandaloneAssets
Total assets¥2.2bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥1.5bnat 2022-09-30StandaloneLiabilities
Total liabilities¥1.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥755mat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥680mat 2022-09-30StandaloneCash and deposits
Cash and deposits¥720mat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥561mat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥538mat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥485m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥177m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥320m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥172m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥17m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥18m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥50.662022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.512022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥95.82021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥42.632021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥20.812021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.472022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.282021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio33.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,369at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥39m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥199m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥329m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥25m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2022-04-01 → 2022-09-30−¥8m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥160m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥492m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥454m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥8m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥154m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥62m
jpcrp040300-q2r_E37198-000Care Planning Servicereportable segmentsegment profit2021-04-01 → 2021-09-30−¥849,000
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥2.5bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥262m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥37m
jpcrp040300-q2r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2021-04-01 → 2021-09-30¥14m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2021-04-01 → 2021-09-30¥192m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2021-04-01 → 2021-09-30¥114m
—segment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥388m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥380m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 437
ItemContextValueUnit
Cash and cash equivalents (5-year summary)Prior1QuarterInstant_NonConsolidatedMember560852000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant_NonConsolidatedMember679958000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant_NonConsolidatedMember719557000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration_NonConsolidatedMember20.81
Basic earnings loss per share (5-year summary)CurrentQuarterDuration_NonConsolidatedMember24.51
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember3568400
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember3568700
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant3568400
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant3568700
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember683000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1914
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember450000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1261
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember420000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.1177
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember349000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0980
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember256000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0717
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember250000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0701
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember211000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0592
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember98000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0277
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember79000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0221
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember70000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0197
Number of shares heldCurrentQuarterInstant2868000
Shareholding ratioCurrentQuarterInstant0.8038
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember3567200
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember35672
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember1200
Number of shares issued shares voting rightsCurrentQuarterInstant3568400
Number of voting rights issued shares voting rightsCurrentQuarterInstant35672
Cash and depositsPrior1YearInstant_NonConsolidatedMember719557000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember679958000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember996103000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember1049064000JPY
MerchandisePrior1YearInstant_NonConsolidatedMember156172000JPY
MerchandiseCurrentQuarterInstant_NonConsolidatedMember195827000JPY
Other caPrior1YearInstant_NonConsolidatedMember24224000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember30427000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember1896058000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass